WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan

A trial beginning today targeting the nation's largest health insurer, WellPoint Inc., and its California subsidiary, Anthem Blue Cross, illustrates how difficult, and how necessary, President Obama's call to curb insurance company abuses will be, said Consumer Watchdog. The Los Angeles trial alleges that Blue Cross has automatically denied requests for out-of-network liver transplants, no matter what a doctor says is necessary, often without even reviewing all patient records. The trial will shed light on the delay and denial of life-saving treatment in cases that might cut into insurance company profits, the consumer advocacy group said.

Consumer Watchdog urged...

Want to see the full article?

• Purchase this article for only $3.00